(Q42476875)

1 November 2017

Indinavir alters regulators of protein anabolism and catabolism in skeletal muscle (English)

1 reference

1 November 2017

1 reference

Ly Q Hong-Brown

1

1 reference

1 November 2017

Anne M Pruznak

2

1 reference

1 November 2017

Robert A Frost

3

1 reference

1 November 2017

Thomas C Vary

4

1 reference

1 November 2017

Charles H Lang

5

1 reference

1 November 2017

12 April 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 November 2017

1 reference

1 November 2017

289

1 reference

1 November 2017

E382-90

1 reference

1 November 2017

3

1 reference

Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors

1 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

HIV-associated lipodystrophy syndrome: description and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Association between sexual disturbances and sexual hormones with specific antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

New anti-HIV agents and targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Ribosomal S6 kinase signaling and the control of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Measuring muscle protein turnover in vivo: what can 3-methylhistidine production tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Regulation of translation initiation by FRAP/mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Regulation of eIF-4E BP1 phosphorylation by mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Indinavir induces acute and reversible peripheral insulin resistance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Select HIV protease inhibitors alter bone and fat metabolism ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Adherence and effectiveness of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

HIV protease inhibitors acutely impair glucose-stimulated insulin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

PHAS-I as a link between mitogen-activated protein kinase and translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Differential effect of sepsis on ability of leucine and IGF-I to stimulate muscle translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Alcohol myopathy: impairment of protein synthesis and translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Metabolic effects of indinavir in healthy HIV-seronegative men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Initiation of protein synthesis in eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00591.2004

10.1152/AJPENDO.00591.2004

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference